H.C. Wainwright analyst Andrew Fein raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $35 from $30 and keeps a Buy rating on ...

Sadly, some of the strongest characters that stand out in the books didn't make it into any of the Harry Potter movies.

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for ...

Harry Potter introduced viewers to a world of wizards, spells, and fantastical creatures. Based on a book series of the same ...

Squid Game Season 2 made its highly anticipated premiere with Netflix earlier this week, and it’s already breaking all sorts of records with the streamer in its first few days alone. Squid Game was ...

Rowling's Harry Potter book series was adapted into eight fantasy films, starting with Harry Potter and the Philosopher's Stone (2001) and concluding with Harry Potter and the Deathly Hallows – Part 2 ...

Harry Potter and the Prisoner of Azkaban is a fantasy film directed by Alfonso Cuarón with a script by Steve Kloves, released in 2004. It is based on J. K. Rowling's 1999 book of the same name. It is ...

The Harry Potter series is getting adapted all over again, and there are plenty of things it should do differently this time. By expanding from about one movie per book into perhaps more than a season ...

Here are the most exciting books we're most looking forward to sharing in 2025 Lizz Schumer is the senior books editor at PEOPLE. She has been working at PEOPLE since 2024. Her work has previously ...